Augmedix to Participate at the 2022 JMP Securities Technology Conference

Rhea-AI Summary

Augmedix, Inc. (Nasdaq: AUGX) has announced its participation in the JMP Securities Technology Conference taking place in San Francisco. CEO Manny Krakaris will present on March 8, 2022, at 11:30 a.m. Pacific Time. Interested individuals can access the live and archived webcast via the company’s Investor Relations webpage.

Augmedix specializes in automated medical documentation and data services, which aid healthcare providers by converting patient-physician conversations into structured medical notes, allowing for more efficient patient care.

SAN FRANCISCO, March 01, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be presenting in the upcoming JMP Securities Technology Conference in San Francisco.

Manny Krakaris, Chief Executive Officer of Augmedix, will be presenting on Tuesday, March 8, 2022, at 11:30 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://ir.augmedix.com/news-events/ir-calendar.

About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists. To learn more about Augmedix, visit augmedix.com.

Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com

FAQ

When is Augmedix presenting at the JMP Securities Technology Conference?

Augmedix will present on March 8, 2022, at 11:30 a.m. Pacific Time.

Where can I watch the Augmedix conference presentation?

The presentation can be accessed via the Investor Relations section of the Augmedix website.

What services does Augmedix provide?

Augmedix offers automated medical documentation and data services that convert conversations between physicians and patients into structured medical notes.

What is the stock symbol for Augmedix?

The stock symbol for Augmedix is AUGX.

Who is the CEO of Augmedix?

The CEO of Augmedix is Manny Krakaris.